Antidiabetic tricyclic compounds

Details for Australian Patent Application No. 2008319418 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Liang, Gui-bai; Liu, Weiguo; Kim, Dooseop; Finke, Paul E.; Liao, Xibin; Lin, Songnian; Yang, Lihu

Agent Spruson & Ferguson

Pub. Number AU-A-2008319418

PCT Pub. Number WO2009/058237

Priority 61/000,857 29.10.07 US

Filing date 27 October 2008

Wipo publication date 7 May 2009

International Classifications

C07D 265/38 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

Event Publications

13 May 2010 PCT application entered the National Phase

  PCT publication WO2009/058237 Priority application(s): WO2009/058237

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008319419-Substituted diazepan orexin receptor antagonists

2008319411-Method and apparatus for a converter valve